Sun Pharma Advanced Research Company has informed that a meeting of the Board of Directors of the Company will be held on July 29, 2016, to consider and take on record, the un-audited financial results of the Company for the quarter ended June 30, 2016 (Q1). Further, that the trading window for trading by designated persons shall be closed from July 20, 2016 to August 02, 2016.
The above information is a part of company’s filings submitted to BSE.